ImmunityBio Inc. (IBRX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for ImmunityBio Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$8.81
+2.09% today
Market cap
$9.1B
Overall quality
—
Kronos AI 30-day
−12.2%
0 of 8 simulated paths end higher
ImmunityBio Inc. (IBRX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $9.1B. It trades at $8.81, up 2.09% today. 4 analysts' average target of $14.25 implies +61.7% from today's price. Kronos AI's 30-day forecast is −12.2% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $14.25 |
| Low – high | $12.00 – $16.00 |
| Analysts | 4 |
| Upside to average | +61.7% |
Kronos AI 30-day forecast
| Expected close | $7.57 (−12.2%) |
| Likely range | −18.1% … −6.4% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.